Today Dr. Dipnarine Maharaj will be speaking to the Southeast Chapter of the Scleroderma Foundation in Boynton Beach Florida. Please see the information below:
Thursday Evening
October 3, 2013
at 6:00 pm - 7:00 pm
for a presentation
by
Dr. Dipnarine Maharaj M.D., MB, ChB, FRCP (Glasgow), FRCP (Edinburgh),
Dipnarine Maharaj is an American physician, author, clinical researcher and Founder & Medical Director of the South Florida Bone Marrow Stem Cell Transplant Institute and the Stem Cell Cryobank located in Boynton Beach Florida. The Institute is one of the few completely outpatient stem cell transplant facilities in the US. As an expert in stem cells, he has conducted research regarding adult stem cell therapies and their impact on the immune system in the treatment of cancers and other diseases. He has served as a professor at the University of Miami, Nova Southeastern University, and Florida Atlantic University.
Dr. Maharaj performs stem cell/bone marrow transplants for patients with leukemia and other cancers and blood disorders. More recently, he has been advocating collecting and storing healthy adult stem cells for future use as the number of approved diseases for treatment with adult stem cells grows. He is also developing clinical protocols using the individual’s own stem cells for the treatment of chronic diseases such as diabetes and neurodegenerative disorders such as strokes, Parkinson’s disease, Alzheimer’s disease, and cardiac diseases.
Maharaj is the author of more than 80 published research papers and abstracts on bone marrow and stem cell transplantation for blood disorders, cancers, Parkinson’s disease, diabetes, and other inflammatory diseases. He has also developed a new protocol for Parkinson’s disease patients, for which he was awarded a United States Patent. Currently he is running an FDA approved Phase I/Phase II Clinical Trial for solid tumor cancers. He was profiled by Suzanne Somers for his work with cancer in her book Bombshell: Explosive Medical Secrets that will Redefine Aging (2012) where she categorized him as “America’s Leading Expert on Stem Cell Technologies”. In association with A4M (American Academy of Anti-Aging Medicine) he created the Stem Cell Fellowship, an educational certification program for physicians interested in adult stem cell patient treatment.
Dipnarine Maharaj was born at Palmyra in the suburbs of San Fernando, Trinidad and raised in Scotland. He received his medical degree in 1978 from the University of Glasgow Medical School, Scotland. He completed his internship and residency in Internal Medicine and Hematology at the University's Royal Infirmary. He completed a three-year fellowship in Hematology, Oncology, and Bone Marrow Transplantation.
Following his training, Dr. Maharaj worked with Alan Burnett, M.D., chairman of the United Kingdom Medical Research Council's Acute Leukemia trials. Together, they helped develop the first Scottish Bone Marrow/Stem Cell Transplant Program and they were one of the first centers to publish their data on the use of autologous bone marrow transplantation for acute myeloid leukemia.
Dr. Maharaj moved to the United States in 1990 to join the University of Miami’s (UM) bone marrow transplant team which was led by Dr. John Byrnes, who had trained with Dr. George Santos at Johns Hopkins Bone Marrow Transplant Center. Dr. Byrnes and Dr. Maharaj performed the first autologous bone marrow transplant at the University of Miami in 1991.
Following a three-year tenure at UM, Dr. Maharaj began a totally outpatient Bone Marrow/Stem Cell Transplant Institute at Florida Medical Center in 1995. In 1997, he aligned with Bethesda Health Care System in Boynton Beach continuing as medical director of the Bone Marrow/Stem Cell Transplant Institute at Bethesda, developing the outpatient program, and eventutally took the Institute independent by 2001. The Institute is FDA registered, Joint Commission Accredited (JCAHO), and accredited by the AABB (American Association of Blood Banks). It is an affiliate of the H. Lee Moffitt Cancer.
During his career in the United States, Dr. Maharaj has conducted research as the Principal Investigator for organizations & corporations such as the American Cancer Society, Immunex, Genentech, Amgen, Biomira, and Genzyme. He currently is on staff at Bethesda Memorial Hospital in Boynton Beach, FL where he was awarded Physician of the Month in April 2010.
1974: British Council Scholarship in Medicine 1976: Certificate of Merit in Internal Medicine, Surgery, Hematology 1977: Macleod Medal and Prize in Medicine and Surgery 1986: Traveling Fellowship, Royal College of Physicians of Edinburgh 1990: Myre Sim Traveling Fellowship, Royal College of Physicians of Edinburgh 2000-2009: Culpepper Foundation Grant 2007: Coley-Bankhead Grant
Dr. Maharaj is one of the inventors of the Parkinson’s treatment that was awarded a U.S. patent in May 2010 (US 7723302). The invention relates to the discovery that in an animal model of Parkinson's disease (PD), administration of granulocyte colony-stimulating factor (G-CSF) to rodents having 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD restored the function of dopamine neurons. In these animals, G-CSF treatment increased the number of dopamine neurons in the substantia nigra (SN), G-CSF treatment partially restored the nigrostriatal pathway, and G-CSF restored the function of dopamine to the level before MPTP treatment. The invention also relates to the discovery that treatment of a human patient with corticobasilar ganglionic degeneration, a rare progressive neurological disorder characterized by Parkinsonism and coritcal dysfunction, with G-CSF resulted in a significant improvement in the patient's Unified Parkinson's Disease Rating Scale evaluations as well as measures of activity of daily living. The invention further relates to the discovery that G-CSF treatment of a patient who had suffered an acute stroke resulted in a significant improvement in neurological function, the patient having minimal observable disability seven years later. The above method can be used to treat Alzheimer’s disease, stroke, and spinal cord injuries as well.
The South Florida Bone Marrow/Stem Cell Transplant Institute, with Dr. Dipnarine Maharaj M.D. as the principal investigator, is running an FDA approved IND (Investigational New Drug) Phase I/Phase II clinical trial (Clinical trial 08001-BMSCTI) studying a novel cancer therapy using transfusions of white blood cells from healthy donors. It will study the ability to transfer naturally occurring cancer-killing activity (CKA) in the granulocytes of selected donors into the body of a cancer patient.
The new cancer therapy was developed from the research results from Dr. Zheng Cui of Wake Forest University and Dr. Cui’s studies of natural cancer resistance in a unique strain of lab mouse (SR/CR mice) and in some healthy humans.
In 2010, Dr. Maharaj received a grant from the Life Extension Foundation for the clinical trial, which provided initial funding to start the study. Dr. Maharaj notes that the critical research could not take place without the help from the Life Extension Foundation.
The Life Extension Foundation does not have any financial interest in the outcome of the research project. They simply want to discover the means to possibly help cure cancer. The foundation wants to be able to recommend a validated cure for cancer to the millions of supporters following the organization.
Suzanne Somers: Bombshell Explosive Medical Secrets that will Redefine Aging[edit source | editbeta]
At the request of noted futurist and inventor Ray Kurzweil, Suzanne Somers dedicated a chapter of her book Bombshell: Explosive Medical Secrets That Will Redefine Aging (2012) to Dr. Dipnarine Maharaj and his advancements in stem cell research. She acknowledged the breakthroughs he has made in Parkinson’s disease and cancer treatment. Somers also interviewed Dr. Maharaj on air on her talk show, Suzanne Somers Breaking Through, about his clinical trial and voiced personal support for the study. Somers even went so far as to say that she believes Dr. Maharaj possesses the ability to one day find a cure for cancer and has discussed his research on the NBC Today show with Savannah Guthrie.
Based on the work of Dr. Zheng Cui PhD, Dr. Dipnarine Maharaj MD, FACP, Medical Director of the South Florida Bone Marrow/Stem Cell Transplant Institute...
Jul 16, 2013 - Dr. Dipnarine Maharaj is the Medical Director and founder of the South Florida Bone Marrow/Stem Cell Transplant Institute, one of the few ...
Internationally Recognized Stem Cell Transplant Physician & Research in the fight against Cancer, Parkinson's Disease, Leukemia, Alzheimer's Disease, ...
View Dipnarine Maharaj's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Dipnarine Maharaj...
Dr. Dipnarine Maharaj's Message: The ability of stem cells to repair the cells and tissues of the body is an observation that I have made in the many years that I ...
Miami/Fort Lauderdale Area - electronics technician at dmelectronics
View dipnarine maharaj's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like dipnarine maharaj...
Dr. Dipnarine Maharaj wrote 2 days ago : The Role of Stem Cells in Regenerative Medicine and ... Stem Cells and Aging Written By Dr. Dipnarine Maharaj M.D..
Several friends and I had the opportunity to attend the Singularity Summit in Salt Lake City last Saturday. The event was organized by the Singularity Institute and Robert Brazell, founder of Overstock.com. The Singularity Institute is an affiliate of Humanity+, which is also affiliated with the Mormon Transhumanist Association.
The topic was emerging technology. Robert Brazell welcomed us with the intriguing notion that reason, rather than knowledge, has become a key scarce resource. That idea was echoed immediately afterward by Michael Vassar, president of the Singularity Institute, who told us that we should seek to understand how to think well enough to teach thinking to a machine.
Next, several speakers focused on emerging medical and health technology. Deepa Kulkarni recounted her personal experience losing the tip of her finger in an accident and using regeneration powder from Acell to regrow it. The pictures of her finger after the accident weren't pretty, of course, but now her finger, which I had a chance to look at close up, looks wonderfully normal! Zheng Cui talked to us about his cancer research. He explained that cancer resistance can be bred into mice with 40% inheritance, and cancer appears to be seasonal (persons in geographies with winter are four times more likely to get cancer). Now, he's working on a project to transfer white blood cells from cancer resistant humans to those inflicted with cancer. Dipnarine Maharaj followed up, advising us that we should all bank our own stem cells, for use in future regenerative therapies, while we are still young and healthy.
Jaan Tallinn talked to us about his technology ventures, notably Skype. He commented that we should look for actions that transfer probability from dystopian to utopian futures, and intelligence is the meta-solution to the class of problems associated with dystopian futures. I don't entirely agree with this idea, at least so far as he presented it. The solution is not merely intelligence, but rather benevolent intelligence. He might agree with that, but I didn't have an opportunity to ask.
Ray Kurzweil beamed in (like he did for the Singularity University FutureMed executive program I attended recently). He spoke on exponentially advancing technology, as usual. He mentioned that health and medicine are now becoming information technologies; and, once something is an information technology, it progresses exponentially. Look for revolutionary advances in these domains this decade! He commented further that genes are literally software programs, and we will eventually update our biological code like we now update smart phone code. A few other comments from Ray also caught my attention: inducing stem cells from skin cells is getting around ethical concerns with use of embryonic cells, the amount of data transmitted wirelessly has been increasing exponentially for a century, computing capacity is now doubling every eleven months, 3D printing will reach the nanoscale by the 2020s, and we'll meet the world's energy needs via solar energy within 20 years. During the Q&A, Ray mentioned that information immediacy is invoking natural human empathy on a much larger scale than in the past. True as that may be, we should not allow such perspectives to lull us away from working actively to improve humanity's benevolence to malevolence ratio.
Aubrey de Grey pounced on the problem of aging. His first presented statistic, as usual, was that 150,000 humans are dying each day, and two thirds (100,000) of them are dying as a consequence of aging. In the United States, around 90% of deaths are a consequence of aging. Aging, as defined by Aubrey, is defined as pathology from damage from metabolism. He advocates intervening by maintaining (constantly repairing) the body rather than using the traditional approaches of gerontology or geriatrics. He commented that advocating cultural and financial support of anti-aging research is essential to ensuring more rapid progress to solutions. I strongly support Aubrey's efforts. We have a moral imperative (even a Christian duty, for those of us that identify as Christians) to use the means at hand to reduce and eliminate the suffering and other negative consequences of aging.
Finally, we heard from a representative of Khan Academy (an awesome online education resource) and Luke Nosek, a founder of PayPal, who encouraged us to build positive pathways to the Singularity -- the rapidly approaching technological event horizon, beyond which it's difficult to predict the nature of further progress.
I thoroughly enjoyed the Singularity Summit, and I'm particularly happy that this event happened in Salt Lake City. Apparently the Singularity Institute lost money on this event due to lower than expected attendance. In part, this was caused by poor publicity. Although I'm well connected with transhumanists and singularitarians in the Salt Lake City area, I didn't hear about the event until just a few days before it happened. That can easily be fixed next time. Another concern is that the event needs sponsors in the area. If you have a lead on a sponsor for events like this in the Salt Lake City area in the future, please contact me. Thanks!
Post Name: Dipnarine Maharaj in the News: Singularity Institute Summit in Salt Lake City. Dr. Dipnarine Maharaj of the South Florida Bone Marrow Stem Cell Transplant Institute is a well known researcher and treatment physician of cancer, Parkinson's disease, Alzheimer's disease, diabetes, and strokes.
The collection and storage of
adult stem cells from a healthy individual is an elective procedure. It is an
opportunity that an individual should know about, and we would like to give you
all the facts so that you can make your own informed decision. The collection
and storage of stem cells is done safely on a daily basis by thousands of
healthy individuals who donate their own stem cells to a related or unrelated
patient who is suffering from a disorder of the blood or an immune deficiency
state. The process by which the stem cells are collected is the same as when a
blood donor goes to the blood bank to donate platelets. This process is called apheresis. The difference in the case
of a healthy individual donating stem cells is that they are given a
medication, which is injected subcutaneously for five days. The stem cells are
then collected (by arm veins in most cases) using the apheresis machine.
The
opportunity now exists for a healthy individual to collect and store their own
stem cells for their own personal use in the future, should they need it. The
idea is not new since, for many years, parents have collected and stored the
adult stem cells from cord blood for their baby’s future use, should they need
it.
Transplanted
stem cells are used on a daily basis and adult stem cells have been in use
since the early 60’s for blood disorders. Today, they are used to treat over 80
illnesses, mainly cancers of the blood, such as leukemias, lymphomas, multiple
myelomas, and from matched donors to treat sickle cell anemia and beta
thalassemia.
Many stem cell
experts and transplant physicians believe that there will be breakthroughs in
the future, and these will be helpful particularly to those individuals who
have their own adult stem cells, which have been collected and stored.
Hello My name is Dr. Dipnarine Maharaj. I am a hematologist and oncologist and a bone marrow and stem cell transplant physician with over 30 years of experience. Please view this site and these pages to view my professional qualifications. I look forward to changing the way that patients think of adult stem cell transplants and autologous adult stem cell therapies in the treatment of their diseases like cancer, leukemia, lymphoma, myeloma, Parkinson's disease, Alzheimer's disease, diabetes, Attention Deficit Disorder (ADD), and Traumatic Brain Injury (TBI). Thank you for your time and consideration.
Several friends and I had the opportunity to attend the Singularity Summit in Salt Lake City last Saturday. The event was organized by the